The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Hotjar and Clarity help us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
telephone:
01413308132
email:
Aysin.TulunayVirlan@glasgow.ac.uk
Institute of Infection Immunity, and Inflammation, GBRC Room B428 Level 4, 120 University Place, Glasgow, G12 8TA
Tezcan, N., Özdemir-Kumral, Z. N., Özkan Yenal, N., Çilingir-Kaya, Ö. T., Virlan, A. T. , Özbeyli, D., Çetinel, Ş., Yeğen, B. Ç. and Koç, M. (2022) Nesfatin-1 treatment preserves antioxidant status and attenuates renal fibrosis in rats with unilateral ureteral obstruction. Nephrology Dialysis Transplantation, 37(7), pp. 1238-1248. (doi: 10.1093/ndt/gfac053) (PMID:35218196)
Kelly, L., McGrath, S., Rodgers, L., McCall, K., Tulunay Virlan, A. , Dempsey, F., Crichton, S. and Goodyear, C. S. (2022) Annexin-A1: the culprit or the solution? Immunology, 166(1), pp. 2-16. (doi: 10.1111/imm.13455) (PMID:35146757)
Tom, B. D.M., Symmons, D. and RA-MAP Consortium:, (2018) Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data. RMD Open, 4(2), e000721. (doi: 10.1136/rmdopen-2018-000721) (PMID:30487994) (PMCID:PMC6241979)
Elbasi, M. O., Tulunay Virlan, A. and Eksioglu Demiralp, E. (2018) Killer cell immunoglobulin-like receptor genotypes in the Turkish population. Human Immunology, 79(4), pp. 193-194. (doi: 10.1016/j.humimm.2018.02.008) (PMID:29454072)
Deniz, R., Tulunay-Virlan, A. , Ture Ozdemir, F., Unal, A. U., Ozen, G., Alibaz-Oner, F., Aydin-Tatli, I., Mumcu, G., Ergun, T. and Direskeneli, H. (2017) Th17-inducing conditions lead to in vitro activation of both Th17 and Th1 responses in Behcet’s disease. Immunological Investigations, 46(5), pp. 518-525. (doi: 10.1080/08820139.2017.1306865) (PMID:28414558)
Tezcan, N., Özdemir-Kumral, Z. N., Özkan Yenal, N., Çilingir-Kaya, Ö. T., Virlan, A. T. , Özbeyli, D., Çetinel, Ş., Yeğen, B. Ç. and Koç, M. (2022) Nesfatin-1 treatment preserves antioxidant status and attenuates renal fibrosis in rats with unilateral ureteral obstruction. Nephrology Dialysis Transplantation, 37(7), pp. 1238-1248. (doi: 10.1093/ndt/gfac053) (PMID:35218196)
Kelly, L., McGrath, S., Rodgers, L., McCall, K., Tulunay Virlan, A. , Dempsey, F., Crichton, S. and Goodyear, C. S. (2022) Annexin-A1: the culprit or the solution? Immunology, 166(1), pp. 2-16. (doi: 10.1111/imm.13455) (PMID:35146757)
Tom, B. D.M., Symmons, D. and RA-MAP Consortium:, (2018) Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data. RMD Open, 4(2), e000721. (doi: 10.1136/rmdopen-2018-000721) (PMID:30487994) (PMCID:PMC6241979)
Elbasi, M. O., Tulunay Virlan, A. and Eksioglu Demiralp, E. (2018) Killer cell immunoglobulin-like receptor genotypes in the Turkish population. Human Immunology, 79(4), pp. 193-194. (doi: 10.1016/j.humimm.2018.02.008) (PMID:29454072)
Deniz, R., Tulunay-Virlan, A. , Ture Ozdemir, F., Unal, A. U., Ozen, G., Alibaz-Oner, F., Aydin-Tatli, I., Mumcu, G., Ergun, T. and Direskeneli, H. (2017) Th17-inducing conditions lead to in vitro activation of both Th17 and Th1 responses in Behcet’s disease. Immunological Investigations, 46(5), pp. 518-525. (doi: 10.1080/08820139.2017.1306865) (PMID:28414558)
https://orcid.org/0000-0003-4735-9902